Mortality and Years of Life Lost From Cardiometabolic Diseases in Mexico: National and State-Level Trends, 1998-2022
Public Health Reports,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Jan. 27, 2025
Cardiometabolic
diseases
(CMDs)
are
highly
prevalent
in
Mexico.
We
analyzed
the
evolution
of
mortality
from
CMDs
Mexico
at
national
and
state
level,
as
well
their
contribution
to
years
life
lost
(YLL),
1998
through
2022.
conducted
an
observational
study
based
on
a
public
database.
calculated
age-standardized
rates,
joinpoint
regression
analyses
determine
changes
trend
magnitude
over
time,
YLL
among
people
nationally
by
state.
From
2022,
rate
increased
14.9%
These
rates
reached
highest
levels
2020
2021
during
COVID-19
pandemic.
In
aged
0
84
had
3.9
CMDs,
which
represented
increase
0.4
compared
with
1998.
for
heart
disease,
diabetes
mellitus,
hypertension
but
decreased
stroke.
Mortality
have
steadily
Mexico,
driven
mainly
disease
mellitus.
attributable
could
be
prevented
early
care
health
prevention
policies.
Decision
makers
should
work
implement
robust
enduring
policies
focused
shared
risk
factors
underlying
these
diseases.
Language: Английский
Association between SARS-CoV-2 viral load and serum biomarkers with mortality in Mexican patients
Journal of Education and Health Promotion,
Journal Year:
2025,
Volume and Issue:
14(1)
Published: March 1, 2025
BACKGROUND:
The
coronavirus
disease
2019
(COVID-19)
pandemic
has
resulted
in
high
mortality
among
hospitalized
patients;
thus,
identifying
markers
treating
these
patients
is
essential.
To
evaluate
the
association
between
viral
load
and
serum
biomarkers
with
COVID-19.
MATERIALS
AND
METHODS:
A
retrospective
cohort
study
was
conducted
198
inpatient
records
from
a
tertiary
hospital
Mexico
City
January
April
2021.
severe
acute
respiratory
syndrome
2
(SARS-CoV-2)
death
due
to
COVID-19
assessed
using
Cox
regression
models.
RESULTS:
median
age
54.9
years,
61.6%
were
males.
rate
43.4%.
After
adjusting
for
potential
confounders,
higher
[adjusted
hazard
ratio
(aHR)
=
1.56;
95%
confidence
interval
(95%
CI)
1.01,
2.42;
P
value
0.041];
concentrations
of
BUN
(aHR
4.87;95%
CI
2.70,
8.79;
0.001),
creatinine
1.60;95%
2.54;
0.043),
osmolality
4.37;95%
2.34,
8.14;
glucose
2.41;95%
1.40,
4.18;
0.001)
more
likely
have
fatal
prognosis.
Conversely,
risk
lower
lymphocytes
0.47;95%
0.30,
0.72;
0.001).
CONCLUSION:
SARS-CoV-2
such
as
BUN,
creatinine,
glucose,
osmolarity,
could
help
physicians
identify
individuals
who
require
closer
monitoring.
Language: Английский